<DOC>
	<DOC>NCT00434746</DOC>
	<brief_summary>The purpose of this study is to assess the safety and tolerability of ascending single IV doses of ILV-094 (an investigational drug) and one SC dose of ILV-094 in healthy subjects.</brief_summary>
	<brief_title>Study of the Safety, Tolerability, PK, and PD of ILV-094 Administered IV or SC to Healthy Subjects</brief_title>
	<detailed_description>This is a randomized, double-blind, placebo-controlled, inpatient/outpatient, sequential-group study of ascending single IV doses of ILV-094 administered to healthy Japanese male subjects.</detailed_description>
	<criteria>Men aged 20 to 45 years inclusive at screening. Body mass index in the range of 17.6 to 26.4 kg/m2 and body weight&gt;45. Nonsmoker or smoker of fewer than 10 cigarettes per day. Must be abstain from smoking during inpatient stay. Healthy as determined by the investigator on the basis of screening evaluation.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>